Tazarotene Cream
Product Images NDC 0713-0765

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tazarotene (NDC 0713-0765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 G Carton (30g Carton)

30 G Carton (30g Carton)
Tazarotene cream is a prescription-only medication used for topical application only. It contains Tazarotene as an active ingredient and is not suitable for oral, ophthalmic, or intravaginal use. The cream is used for treating psoriasis and acne. The cream should be applied once a day in the evening to affected areas. If any emollients are used, they should be applied an hour before applying this cream. The cream should not be applied to unaffected or sensitive skin to avoid any irritation. This medication is distributed by Cosstts Pharmacutioae Inc. and should be stored between 20°C to 25°C. Additional details and full prescribing information can be found in the patient leaflet that accompanies this medication.*
FDA Label Image

30 G Tube (30g Tube)

FDA Label Image

60 G Carton (60g Carton)

60 G Carton (60g Carton)
Tazarotene Cream is a topical medication for the treatment of psoratic lesions and acne. The active ingredient is Tazarotene 0.1% w/w, and inactive ingredients include Benzy alcohol, carbomer copolymer, and sorbitan monooleate. Its dosage involves applying Tazarotene Cream once per day in the evening, to the skin where lesions appear, using enough to cover only the lesion with a thin film. It is essential to keep it out of the reach of children.*
FDA Label Image

60 G Tube (60g Tube)

60 G Tube (60g Tube)
This is a topical medication labeled Tazarotene, with NDC code 0713-0670-60. It contains 0.1% of Tazarotene as its active ingredient, and should only be used topically. The medication should not be taken orally, ophthalmically, or intravaginally. It contains additional inactive ingredients to help with application, and the usual dosage is outlined in the accompanying patient leaflet and full prescribing information. The medication should be stored between 20°C to 25°C (68°F to 77°F), with slight excursions allowed. This medication is distributed by Cosette Pharmaceuticals, Inc.*
FDA Label Image

Structural Formula (Tazstructure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.